(Q44170227)

30 November 2017

title

HPLC assay for albendazole and metabolites in human plasma for clinical pharmacokinetic studies (English)

1 reference

30 November 2017

1 reference

Lawrence Fleckenstein

series ordinal

3

1 reference

30 November 2017

Dennis Kitzman

1

1 reference

30 November 2017

Kuei-Ju Cheng

series ordinal

2

1 reference

30 November 2017

publication date

1 October 2002

1 reference

Journal of Pharmaceutical and Biomedical Analysis

30 November 2017

published in

1 reference

30 November 2017

volume

30

1 reference

30 November 2017

issue

3

1 reference

30 November 2017

page(s)

801-813

1 reference

Therapy of human hydatid disease with mebendazole and albendazole

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900382-5

7 January 2021

Albendazole in treatment of human cystic echinococcosis: 12 years of experience

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900382-5

7 January 2021

Treatment of the microfilaraemia of asymptomatic brugian filariasis with single doses of ivermectin, diethylcarbamazine or albendazole, in various combinations.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900382-5

7 January 2021

The role of albendazole in programmes to eliminate lymphatic filariasis

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900382-5

7 January 2021

Comparative enantioselectivity in the sulphoxidation of albendazole in man, dogs and rats

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900382-5

7 January 2021

The metabolism of benzimidazole anthelmintics

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900382-5

7 January 2021

Analysis of benzimidazoles in body fluids by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900382-5

7 January 2021

Simultaneous determination of albendazole and its principal metabolites in plasma by normal phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900382-5

7 January 2021

Rapid and sensitive method for the determination of albendazole and albendazole sulphoxide in biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900382-5

7 January 2021

Sensitive high-performance liquid chromatographic assay for albendazole and its main metabolite albendazole sulphoxide in plasma and cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900382-5

7 January 2021

Determination of Albendazole Metabolites in Plasma by HPLC

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900382-5

7 January 2021

Quantitative determination of albendazole and its main metabolites in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900382-5

7 January 2021

Simultaneous determination of albendazole sulfoxide enantiomers and albendazole sulfone in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900382-5

7 January 2021

Determination of albendazole and its main metabolites in ovine plasma by liquid chromatography with dialysis as an integrated sample preparation technique

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900382-5

7 January 2021

Therapeutic drug monitoring of albendazole: determination of albendazole, albendazole sulfoxide, and albendazole sulfone in human plasma using nonaqueous capillary electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900382-5

7 January 2021

Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900382-5

7 January 2021

Bioanalytical method validation--a revisit with a decade of progress

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900382-5

7 January 2021

10.1016/S0731-7085(02)00382-5

Identifiers

DOI

1 reference

30 November 2017

1 reference